DELFI Diagnostics Employee Directory
Medical and Diagnostic LaboratoriesCalifornia, United States51-200 Employees
Delfi Diagnostics develops blood-based tests to detect and monitor cancer by analyzing patterns of DNA fragmentation in a patient’s blood. The tests rely on genome-wide analysis of circulating DNA to identify signals associated with cancer, offering a noninvasive option for early detection and ongoing disease tracking. In oncology, the company serves pharmaceutical companies seeking objective data to inform drug development decisions. Based in Palo Alto, California, the company operates in the medical and diagnostic laboratories sector, positioned at the intersection of genomics and cancer diagnostics. It is a relatively small to mid-sized organization focused on blood-based genomic testing. In April 2026, Delfi announced the appointment of Charles Newton to its board of directors.